 |
EDITORIAL
Gene therapy for ischemic heart disease: how far are we from clinical
application?
Frans C. Visser |
|
BASIC
ARTICLE
Potential of gene therapy for the treatment of metabolic abnormalities
in the heart
Martinus T. Spoor, Jason R.B. Dyck |
|
MAIN
CLINICAL ARTICLE
Gene transfer for therapeutic angiogenesis in cardiovascular
diseases
Peter R. Vale, Douglas W. Losordo |
|
IMAGING
Arteriogenesis: nature’s way to maintain structure
and metabolism in
the presence of occluded arteries
Wolfgang Schaper, Matthias Heil, Frederic Pipp |
|
NEW
THERAPEUTIC APPROACHES
Future developments in gene therapy
Andrew H. Baker |
|
FOCUS ON TRIMETAZIDINE (VASTAREL)
Clinical value of combined hemodynamic and metabolic agents in the
treatment of stable angina
Ioana Holban, Thierry Hénane |
|
CASE
REPORT
Enzyme replacement therapy in Anderson-Fabry cardiomyopathy
Christoph Kampmann, Catharina Whybra, Frank A. Baehner, Michael Beck |
|
REFRESHER
CORNER
Methods of gene transfer to the myocardium
Jean-Jacques Mercadier, Damien Logeart |
|
FEATURED
RESEARCH
- Short-term treatment with ranolazine improves mechanical
efficiency in dogs with chronic
heart failure
- Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose |
|
ALL
ARTICLES AS PDF FILE
For easy printing and true layout; to be viewed with free Adobe® Acrobat® Reader® |
